反応式
[C:1]([O:10]C1C=CC=CC=1)(=O)[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[CH2:17]([C:19]1[CH:25]=[CH:24][CH:23]=[CH:22][C:20]=1[NH2:21])[CH3:18]>>[CH2:17]([C:19]1[CH:25]=[CH:24][CH:23]=[CH:22][C:20]=1[NH:21][C:1](=[O:10])[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4])[CH3:18]参加物
3
実験手順
The 2′-ethyl-salicylanilide was prepared by condensing phenyl salicylate with 2-ethylaniline then purified as described in Example 2a. The ligand mixture was then prepared from 2′-ethyl-salicylanilide and 1,1′-bi-2-naphthol using the procedure described in Example 2a. 31P NMR (121.77 MHz): several peaks between 117.1-118.8 ppm.
後処理
- customthen purified
- customThe ligand mixture was then prepared from 2′-ethyl-salicylanilide and 1,1′-bi-2-naphthol using the procedure
出典と根拠
- ORDレコード
- ord-4bbf13c0bf514f11b9c4464537d267e6
- 出典データセット
- uspto-grants-2003_12
- 特許番号
- US06664427B1
関連ノート
読み込み中…